Selected research
Market Outlook & Growth Opportunities
Global Hospital Infection Management System Market Outlook and Growth Opportunities 2026
Market perspective
The global Hospital Infection Management System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Hospital Infection Management System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Hospital Infection Management System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Hospital Infection Management System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Hospital Infection Management System market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Hospital Infection Management System market include Laoken Medical, STERIS, DNV, Huawei, Dräger, Ecolab, Yinjiang Technology, Yi Ou Technology and Zexin Software, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Hospital Infection Management System market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Hospital Infection Management System and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Hospital Infection Management System revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Hospital Infection Management System market.
Hospital Infection Management System Segment by Company
Laoken Medical
STERIS
DNV
Huawei
Dräger
Ecolab
Yinjiang Technology
Yi Ou Technology
Zexin Software
Siyunshan Technology
Ganxin Information Technology
Peking University Medical Information Technology
Hospital Infection Management System Segment by Type
Endogenous Infection Type
Exogenous Infectious Type
Hospital Infection Management System Segment by Application
Public Hospital
Private Hospital
Hospital Infection Management System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Hospital Infection Management System status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Hospital Infection Management System key companies, revenue, market share, and recent developments.
3. To split the Hospital Infection Management System breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Hospital Infection Management System market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Hospital Infection Management System significant trends, drivers, influence factors in global and regions.
6. To analyze Hospital Infection Management System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hospital Infection Management System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hospital Infection Management System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hospital Infection Management System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hospital Infection Management System industry.
Chapter 3: Detailed analysis of Hospital Infection Management System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Hospital Infection Management System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Hospital Infection Management System in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Endogenous Infection Type
- Exogenous Infectious Type
Applications
- Public Hospital
- Private Hospital
Companies covered
- Laoken Medical
- STERIS
- DNV
- Huawei
- Dräger
- Ecolab
- Yinjiang Technology
- Yi Ou Technology
- Zexin Software
- Siyunshan Technology
- Ganxin Information Technology
- Peking University Medical Information Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Hospital Infection Management System Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Hospital Infection Management System Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Hospital Infection Management System Market Dynamics
- 2.1 Hospital Infection Management System Industry Trends
- 2.2 Hospital Infection Management System Industry Drivers
- 2.3 Hospital Infection Management System Industry Opportunities and Challenges
- 2.4 Hospital Infection Management System Industry Restraints
3 Hospital Infection Management System Market by Company
- 3.1 Global Hospital Infection Management System Company Revenue Ranking in 2025
- 3.2 Global Hospital Infection Management System Revenue by Company (2021-2026)
- 3.3 Global Hospital Infection Management System Company Ranking (2024-2026)
- 3.4 Global Hospital Infection Management System Company Manufacturing Base and Headquarters
- 3.5 Global Hospital Infection Management System Company Product Type and Application
- 3.6 Global Hospital Infection Management System Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Hospital Infection Management System Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Hospital Infection Management System Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Hospital Infection Management System Market by Type
- 4.1 Hospital Infection Management System Type Introduction
- 4.1.1 Endogenous Infection Type
- 4.1.2 Exogenous Infectious Type
- 4.2 Global Hospital Infection Management System Sales Value by Type
- 4.2.1 Global Hospital Infection Management System Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Hospital Infection Management System Sales Value by Type (2021-2032)
- 4.2.3 Global Hospital Infection Management System Sales Value Share by Type (2021-2032)
5 Hospital Infection Management System Market by Application
- 5.1 Hospital Infection Management System Application Introduction
- 5.1.1 Public Hospital
- 5.1.2 Private Hospital
- 5.2 Global Hospital Infection Management System Sales Value by Application
- 5.2.1 Global Hospital Infection Management System Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Hospital Infection Management System Sales Value by Application (2021-2032)
- 5.2.3 Global Hospital Infection Management System Sales Value Share by Application (2021-2032)
6 Hospital Infection Management System Regional Value Analysis
- 6.1 Global Hospital Infection Management System Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Hospital Infection Management System Sales Value by Region (2021-2032)
- 6.2.1 Global Hospital Infection Management System Sales Value by Region: 2021-2026
- 6.2.2 Global Hospital Infection Management System Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Hospital Infection Management System Sales Value (2021-2032)
- 6.3.2 North America Hospital Infection Management System Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Hospital Infection Management System Sales Value (2021-2032)
- 6.4.2 Europe Hospital Infection Management System Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Hospital Infection Management System Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Hospital Infection Management System Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Hospital Infection Management System Sales Value (2021-2032)
- 6.6.2 South America Hospital Infection Management System Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Hospital Infection Management System Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Hospital Infection Management System Sales Value Share by Country, 2025 VS 2032
7 Hospital Infection Management System Country-level Value Analysis
- 7.1 Global Hospital Infection Management System Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Hospital Infection Management System Sales Value by Country (2021-2032)
- 7.2.1 Global Hospital Infection Management System Sales Value by Country (2021-2026)
- 7.2.2 Global Hospital Infection Management System Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.7.2 France Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.14.2 China Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.17.2 India Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Hospital Infection Management System Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Hospital Infection Management System Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Hospital Infection Management System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Laoken Medical
- 8.1.1 Laoken Medical Company Information
- 8.1.2 Laoken Medical Business Overview
- 8.1.3 Laoken Medical Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 8.1.4 Laoken Medical Hospital Infection Management System Product Portfolio
- 8.1.5 Laoken Medical Recent Developments
- 8.2 STERIS
- 8.2.1 STERIS Company Information
- 8.2.2 STERIS Business Overview
- 8.2.3 STERIS Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 8.2.4 STERIS Hospital Infection Management System Product Portfolio
- 8.2.5 STERIS Recent Developments
- 8.3 DNV
- 8.3.1 DNV Company Information
- 8.3.2 DNV Business Overview
- 8.3.3 DNV Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 8.3.4 DNV Hospital Infection Management System Product Portfolio
- 8.3.5 DNV Recent Developments
- 8.4 Huawei
- 8.4.1 Huawei Company Information
- 8.4.2 Huawei Business Overview
- 8.4.3 Huawei Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 8.4.4 Huawei Hospital Infection Management System Product Portfolio
- 8.4.5 Huawei Recent Developments
- 8.5 Dräger
- 8.5.1 Dräger Company Information
- 8.5.2 Dräger Business Overview
- 8.5.3 Dräger Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 8.5.4 Dräger Hospital Infection Management System Product Portfolio
- 8.5.5 Dräger Recent Developments
- 8.6 Ecolab
- 8.6.1 Ecolab Company Information
- 8.6.2 Ecolab Business Overview
- 8.6.3 Ecolab Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 8.6.4 Ecolab Hospital Infection Management System Product Portfolio
- 8.6.5 Ecolab Recent Developments
- 8.7 Yinjiang Technology
- 8.7.1 Yinjiang Technology Company Information
- 8.7.2 Yinjiang Technology Business Overview
- 8.7.3 Yinjiang Technology Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 8.7.4 Yinjiang Technology Hospital Infection Management System Product Portfolio
- 8.7.5 Yinjiang Technology Recent Developments
- 8.8 Yi Ou Technology
- 8.8.1 Yi Ou Technology Company Information
- 8.8.2 Yi Ou Technology Business Overview
- 8.8.3 Yi Ou Technology Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 8.8.4 Yi Ou Technology Hospital Infection Management System Product Portfolio
- 8.8.5 Yi Ou Technology Recent Developments
- 8.9 Zexin Software
- 8.9.1 Zexin Software Company Information
- 8.9.2 Zexin Software Business Overview
- 8.9.3 Zexin Software Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 8.9.4 Zexin Software Hospital Infection Management System Product Portfolio
- 8.9.5 Zexin Software Recent Developments
- 8.10 Siyunshan Technology
- 8.10.1 Siyunshan Technology Company Information
- 8.10.2 Siyunshan Technology Business Overview
- 8.10.3 Siyunshan Technology Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 8.10.4 Siyunshan Technology Hospital Infection Management System Product Portfolio
- 8.10.5 Siyunshan Technology Recent Developments
- 8.11 Ganxin Information Technology
- 8.11.1 Ganxin Information Technology Company Information
- 8.11.2 Ganxin Information Technology Business Overview
- 8.11.3 Ganxin Information Technology Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 8.11.4 Ganxin Information Technology Hospital Infection Management System Product Portfolio
- 8.11.5 Ganxin Information Technology Recent Developments
- 8.12 Peking University Medical Information Technology
- 8.12.1 Peking University Medical Information Technology Company Information
- 8.12.2 Peking University Medical Information Technology Business Overview
- 8.12.3 Peking University Medical Information Technology Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 8.12.4 Peking University Medical Information Technology Hospital Infection Management System Product Portfolio
- 8.12.5 Peking University Medical Information Technology Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst